Marksans Pharma Ltd

NSE: MARKSANS · BSE: 524404 · Pharmaceuticals & Biotechnology · 30 announcements

Share price: ₹325.00
Market cap: ₹14,728 Cr
Revenue (annual): ₹2,951 Cr
Net profit (annual): ₹417.9 Cr
P/E (TTM): 28.5×Sector 47.4×
Promoter holding: 43.87%+0.00% QoQ
FII holding: 17.47%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 6 Other Announcement 4 Financial Results 3 Acquisition 3 Merger & Restructuring 2 Board Meeting Date 2 Annual General Meeting 2 Results Update 1 Promoter Selling (Off-Market) 1 Employee Stock Options 1 Dividend 1 Credit Rating 1 Business Update 1 Board Meeting Outcome 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

27 Aug 2026 15:00 IST BSE

Annual General Meeting

Marksans Pharma Annual General Meeting

Marksans Pharma Limited conducted its 34th Annual General Meeting on August 27, 2026. Shareholders considered the adoption of FY2025-26 financial statements and a dividend of Rs. 0.90 per share.

Read the filing ↗

4 Aug 2026 11:19 IST BSE

Annual General Meeting

Marksans Pharma Annual General Meeting

Marksans Pharma Ltd has issued a notice to convene its 34th Annual General Meeting on August 27, 2026. The meeting will be held via video conferencing.

Read the filing ↗